Developments Fresenius gets FDA breakthrough device designation for hemodialysis system Fresenius Medical Care (NYSE:FMS) received FDA breakthrough device designation for its hemodialysis system, which is being developed for the prevention of blood clotting without the use of blood thinner medication. Many... October 24, 2019